Modulation of the P-Glycoproein-Mediated Intestinal Secretion of Glibenclamide: In Vitro and In Vivo Assessments
2010

Effects of Carbamazepine on Glibenclamide Transport

Sample size: 12 publication 10 minutes Evidence: moderate

Author Information

Author(s): Srirangam P Vidya Sagar

Primary Institution: Vaagdevi College of Pharmacy

Hypothesis

The study aims to evaluate the safety and interaction of glibenclamide therapy in the presence of carbamazepine in healthy rats.

Conclusion

The presence of carbamazepine significantly enhances the plasma concentrations and intestinal secretion of glibenclamide.

Supporting Evidence

  • The rate of glibenclamide accumulation in the intestine was significantly lower when coadministered with carbamazepine.
  • Plasma glibenclamide levels were significantly altered when comparing the results between glibenclamide alone and the combination group.
  • The everted sac technique was confirmed as a useful model for studying P-gp-mediated drug transport.

Takeaway

This study shows that when carbamazepine is given with glibenclamide, more of the drug gets into the blood and intestines, which could help treat diabetes better.

Methodology

The study used both in vitro everted gut sac and in vivo rat models to assess the effects of carbamazepine on glibenclamide transport.

Potential Biases

Potential bias in drug administration and measurement methods could affect the results.

Limitations

The study was conducted on a small sample size of healthy rats, which may not fully represent human responses.

Participant Demographics

Albino rats weighing between 180 and 210 g were used in the study.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.4103/0975-1483.71632

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication